Expired Tender Germany ICB TOT Ref. 33596779

Contract notice: Agents acting Tender in Germany - 33596779

Tender notice from Germany, published on 05 Jun 2019.

Executive Summary

The AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has issued a Tender notice for the procurement of a Contract notice: Agents acting on the renin-angiotensin system in the Germany. This Tender notice was published on 05 Jun 2019 and is scheduled to close on 27 May 2021, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 33596779, while the tender notice number is 260798-2019 and Register on the platform.

Key facts

Summary
Contract notice: Agents acting on the renin-angiotensin system
TOT Ref. No.
33596779
Document Ref. No.
260798-2019
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
05 Jun 2019
Bid deadline
27 May 2021
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Agents acting on the renin-angiotensin system
Description: Contract notice: Agents acting on the renin-angiotensin system
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33622800, 33622800
CPV Description: Agents acting on the renin-angiotensin system.
Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on medicines with the combination of valsartan and amlodipine (ATC code: C09DB01)
Conclusion of a non-exclusive discount agreement according to - 130a Abs SGB V on medicines containing the active substance combination valsartan and amlodipine (ATC code: C09DB01) within the periodfrom 1.8.2019 to 31.7.2021 with possibility of contracting at any time during the term ("open-house-model").
The combination of valsartan and amlodipine (ATC code: C09DB01) is offered by the AOK Die Gesundheitskasse f-r Niedersachsen Period until the entry into force of exclusive contracts as a result of a public procurement procedure in accordance with the regulations of Part 4of the GWB to all interested pharmaceutical companies, without a selection decision, discount contracts. The contract is concluded within the framework of an "open-house model" and acts as a bridge between the start of generic competition (patent expiration) and the awarding of exclusive contracts.The contracts offered are not exclusive, contracts with all market participants (pharmaGerman companies) are desired by the AOK Niedersachsen. In the open-house model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniformly individual negotiations are not conducted in principle. The contract terms are a maximum of twenty-four months, the earliest date of contract is 1.8.2019. All contractsAgege ends not later than 31.7.2021, regardless of the date of the respective contract. An accession or a contract can be made within the twenty-four month period on the first of each month. There is a right to cancel six weeks to the end of each month. The AOK The health fund for Lower Saxony reserves itself, already during the contract running timet replace non-exclusive open-house discount contracts with exclusive discount contracts. With the entry into force of exclusive tender agreements, the open-house contracts will be terminated in accordance with the contractual provisions, ie. H. the open-house contracts end automatically. According to the experience of the AOK Niedersachsen, exclusive discount contracts usually take six to eight monthsIt shall enter into force after the publication of the relevant notice of invitation to tender in the Supplement to the Official Journal of the European Union. The future contractors in the open-house model will be invited to inform themselves regularly in the Supplement to the Official Journal of the European Union for these calls for tenders.
Interested pharmaceutical companies can use the Veapplication documents and the terms of the contract at I.1).
Contracts for the combination of active substances valsartan and amlodipine (ATC code: C09DB01) will be concluded for the first time with effect from 1.8.2019. Interested parties who would like to become partners at this date, have the contract documents to be submitted until 27.6.2019 in the contractsubmit the address specified in the document. It depends on the access at the AOK Lower Saxony. Later contract terms are possible during the twenty-four month maximum term on the first of each month. Organizationally, an advance of usually 35 calendar days on the part of the AOK is necessary to the required work, eg. B. the contract message in the Lauer tax (r) grantto be able to afford. The exact deadlines are announced with the contract documents. This publication does not constitute a public contract within the meaning of the Procurement Coordination Directive (2004/18 / EC) or public procurement law. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, dPublication in the Supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the process name "open procedure", are solely due to the use of this announcement form and the publication platformThis is not connected with the importance of subcontracting regulations, in particular a subordination of subcontracting regulations, unless they are legally binding
Internet address (URL): www.aok.de

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Agents acting on the renin-angiotensin system was 27 May 2021. Bidding is closed.

This tender has been issued by AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33622800 - Agents acting on the renin-angiotensin system.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 33596779. The purchaser document reference is 260798-2019.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.